MoonLake Immunotherapeutics
MLTX
MLTX
27 hedge funds and large institutions have $123M invested in MoonLake Immunotherapeutics in 2022 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 2 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
72% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 25
Holders
27
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$28.9M | |
| 2 | +$5.1M | |
| 3 | +$2M | |
| 4 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
+$1.8M |
| 5 |
AWG
Alpha Wave Global
New York
|
+$1.41M |
Top Sellers
| 1 | -$10M | |
| 2 | -$3.96M | |
| 3 | -$3.96M | |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$3.68M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$3.17M |